Caricamento...
Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients
BACKGROUND: Diabetes mellitus is a chronic metabolic disorder of hyperglycemia. Chronic hyperglycemia produces advanced glycation end products such as the methylglyoxal (MGO) which interferes with cell functions, insulin signaling, and β-cell functions. The present study was conducted to determine t...
Salvato in:
| Pubblicato in: | J Res Med Sci |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327683/ https://ncbi.nlm.nih.gov/pubmed/30693045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jrms.JRMS_1078_17 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|